He wanted cancer patients to know they weren't alone
Richard Scolyer, one of Australia's foremost cancer scientists, died in June aged 59, leaving behind not only a transformed understanding of melanoma but a model of how a person might face their own mortality with curiosity rather than retreat. Diagnosed with glioblastoma three years before his death, he turned his terminal illness into an act of scientific and human generosity — volunteering for experimental treatment, documenting his journey publicly, and insisting that other patients need not face the unknown alone. His life asks a quiet but enduring question of all who follow: when the diagnosis is your own, what do you choose to do with the time that remains?
- A world-leading melanoma pathologist received the very diagnosis he had spent a career helping others survive — an aggressive, fast-moving brain cancer with few good options.
- Rather than withdrawing, Scolyer volunteered his own body for a world-first experimental therapy, turning his illness into a live research frontier watched by patients and scientists globally.
- For three years he documented the brutal realities of glioblastoma treatment openly, dismantling the silence that so often isolates cancer patients and their families.
- Tributes from the Prime Minister, the Governor-General, and communities from Sydney's inner west to rural Tasmania revealed the breadth of a life lived in service to others.
- He died surrounded by his wife and three children, with plans already forming for a state funeral, a permanent memorial, and continued funding drives in his name — the work, by design, outlasting the man.
Richard Scolyer died on a Sunday night in June, aged 59, with his wife Katie and their three children beside him. He had spent nearly three years fighting glioblastoma, one of the most aggressive forms of brain cancer known to medicine. But those who knew him best insist his story was never really about the disease — it was about what he refused to let the disease take from him.
Scolyer had built his career at the Melanoma Institute Australia over more than two decades, helping establish the world's largest melanoma biospecimen bank and developing treatments that would go on to save thousands of lives. In 2024, he and colleague Georgina Long were jointly named Australian of the Year. He understood, in the way only a pathologist can, that a diagnosis is never merely a clinical finding — it is the moment a person's world divides into before and after.
When that moment came for him, he responded with the same disciplined curiosity that had defined his science. He volunteered to test an experimental therapy rooted in melanoma research — a world-first — and shared the experience publicly through interviews and social media, charting the highs and the hard days alike. His family described a man who rose each morning without complaint, determined that no patient walking the same path should feel entirely alone.
His brother-in-law Charles Nicholl, speaking on behalf of the family, remembered a gentle father who passed on to his children — Emily, Matthew, and Lucy — both his love of knowledge and his refusal to accept limits without questioning them. Scolyer pursued funding, challenged conventions, and became a living bridge between laboratory science and the raw human experience of terminal illness.
Prime Minister Anthony Albanese, a long-time neighbour in Sydney's inner west, announced a state funeral and called him one of the country's brightest lights. In his Tasmanian hometown of Bridgenorth, where he remained the football club's number one ticket holder, locals remembered a man who showed up to a community fundraiser just months ago — illness advancing — to speak about the power of coming together.
The Inner West Council announced plans for a permanent memorial. His family asked that those wishing to honour him donate to brain cancer research. In death, as in every year of his working life, Scolyer's attention was fixed on the next patient, the next breakthrough, the next person who might not have to face the unknown alone.
Richard Scolyer died on a Sunday night in June, aged 59, surrounded by his wife Katie and their three children. He had been fighting glioblastoma—an aggressive form of brain cancer—for nearly three years. But the arc of his life was not defined by the disease that killed him. It was defined by what he chose to do with it.
Scolyer was a pathologist who spent more than two decades at the Melanoma Institute Australia, where he helped build the world's largest melanoma biospecimen bank and pioneered treatments that would eventually save thousands of lives. In 2024, he and his colleague Georgina Long were jointly named Australian of the Year for that work. He was the kind of scientist who understood that accurate diagnosis was not just a technical matter—it was the difference between hope and despair for the person on the other side of the microscope.
When he was diagnosed with glioblastoma, Scolyer did not retreat into privacy. Instead, he applied the same rigorous, questioning mind that had defined his career to his own illness. He volunteered to test an experimental treatment based on melanoma science—a world-first therapy that he documented openly, sharing the ups and downs with fellow patients and the public through interviews and social media. For three years, while enduring the ravages of both disease and treatment, he rose each day without complaint and committed himself to helping others who would walk the same uncertain path.
His family released a statement through his brother-in-law, Charles Nicholl, describing a man who was gentle, who loved his children deeply, and who passed on to them his thirst for knowledge and his energy for life. Nicholl spoke of Scolyer's refusal to simply accept a terminal diagnosis—instead, he challenged conventions, pursued funding, and became a bridge between the laboratory and the lived experience of cancer. "He wanted cancer patients to know they weren't alone," his family said.
The tributes came swiftly. Prime Minister Anthony Albanese, who had been Scolyer's neighbour for years in Sydney's inner west, announced a state funeral and called him "one of our brightest lights and one of our biggest hearts." Governor-General Sam Mostyn said his legacy was "simply astonishing." Colleagues at the Melanoma Institute described him as extraordinary—not just as a scientist, but as a human being who made time for clinicians wrestling with difficult cases, understanding that their work mattered.
In his hometown of Bridgenorth, Tasmania, where he grew up and remained the number one ticket holder for the local football club, committee member Marcus Byard remembered him as humble but tough. Even in March of this year, as his illness progressed, Scolyer showed up at a community fundraising event to speak about working as one, about the power of coming together. "Nothing was too hard for him," Byard said.
The Inner West Council, where Scolyer had been named Citizen of the Year in 2025, announced plans for a permanent memorial. His legacy, his family said, would live on through his published research in melanoma, his impact on brain cancer treatment, his honest and raw public conversation about what it means to face a terminal illness, and through the traits he passed on to his children—Emily, Matthew, and Lucy. The family asked that those wishing to honour his memory consider donating to brain cancer research. In death, as in life, Scolyer's focus remained on the next patient, the next breakthrough, the next person who might not have to walk alone.
Citações Notáveis
He walked his 'uncertain path' with courage, determination, and grace, and his legacy will always be with us— Prime Minister Anthony Albanese
Richard was a truly extraordinary pathologist who made generous time for clinicians navigating complex diagnostic cases— Professor Georgina Long, co-director at Melanoma Institute Australia
A Conversa do Hearth Outra perspectiva sobre a história
What made Scolyer different from other cancer researchers who might have kept their diagnosis private?
He didn't see a wall between the scientist and the patient. Most people in his position would have retreated. He did the opposite—he became a translator, showing people what experimental treatment actually looks like, the real costs and possibilities.
Did his openness change how people thought about cancer?
It lifted what he called the veil of secrecy. By refusing to hide his struggle, he gave permission to others to be honest about theirs. That's not small.
His family emphasized that he rose without complaint. Doesn't that risk making suffering seem noble?
I think they meant something different—not that suffering is good, but that he didn't let it stop him from working toward something larger than himself. There's a difference.
What was the experimental treatment he tested?
It was based on melanoma science he'd helped develop. So in a way, he was testing the fruit of his own life's work. That's either poetic or tragic, depending on how you look at it.
Why does a state funeral matter for a scientist?
Because he was more than a scientist by the end. He became a public figure who changed how a nation talks about illness. That's worth marking.